Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BRIEF-Strongbridge Biopharma announces acquisition of U.S. rights to Keveyis from Taro

By: Reuters: Company News
* Strongbridge Biopharma Plc says taro is also eligible to receive additional future payments upon achievement of certain sales unit milestones
Related Stocks:
Strongbridge Bio Ord Taro Pharm Inds
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.